The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma ; volume:37 ; number:1 ; day:21 ; month:5 ; year:2018 ; pages:1-15 ; date:12.2018
Journal of experimental & clinical cancer research ; 37, Heft 1 (21.5.2018), 1-15, 12.2018
- Creator
-
Park, Hye Jeong
- Contributor
-
Bae, Jun Sang
Kim, Kyoung Min
Moon, Young Jae
Park, See-Hyoung
Ha, Sang Hoon
Hussein, Usama Khamis
Zhang, Zhongkai
Park, Ho Sung
Park, Byung-Hyun
Moon, Woo Sung
Kim, Jung Ryul
Jang, Kyu Yun
SpringerLink (Online service)
- DOI
-
10.1186/s13046-018-0772-9
- URN
-
urn:nbn:de:101:1-2018080122404352158035
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Park, Hye Jeong
- Bae, Jun Sang
- Kim, Kyoung Min
- Moon, Young Jae
- Park, See-Hyoung
- Ha, Sang Hoon
- Hussein, Usama Khamis
- Zhang, Zhongkai
- Park, Ho Sung
- Park, Byung-Hyun
- Moon, Woo Sung
- Kim, Jung Ryul
- Jang, Kyu Yun
- SpringerLink (Online service)
Other Objects (12)
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
Olaparib‐Based Photoaffinity Probes for PARP‐1 Detection in Living Cells
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Olaparib: Präzisionsmedizin beim Pankreas- und Prostatakarzinom : PARP-Inhibition in der onkologischen Praxis
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
The CATDAT damaging earthquakes database
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
Damaging the Legitimacy of the Spanish Constitutional Court
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
Olaparib‐Based Photoaffinity Probes for PARP‐1 Detection in Living Cells
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Olaparib: Präzisionsmedizin beim Pankreas- und Prostatakarzinom : PARP-Inhibition in der onkologischen Praxis
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
The CATDAT damaging earthquakes database
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
Damaging the Legitimacy of the Spanish Constitutional Court
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
Olaparib‐Based Photoaffinity Probes for PARP‐1 Detection in Living Cells
Study protocols of three parallel phase 1 trials combining radical radiotherapy with the PARP inhibitor olaparib
Olaparib: Präzisionsmedizin beim Pankreas- und Prostatakarzinom : PARP-Inhibition in der onkologischen Praxis
Targeting autophagy potentiates the anti-tumor effect of PARP inhibitor in pediatric chronic myeloid leukemia
The CATDAT damaging earthquakes database
An evaluation in vitro of PARP-1 inhibitors, rucaparib and olaparib, as radiosensitisers for the treatment of neuroblastoma
CDC7 Inhibition Potentiates Antitumor Efficacy of PARP Inhibitor in Advanced Ovarian Cancer
Damaging the Legitimacy of the Spanish Constitutional Court
Correlation between molar activity, injection mass and uptake of the PARP targeting radiotracer [18F]olaparib in mouse models of glioma
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status